Article
RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer.
Cancer letters - 1 Aug 2026
Qin Gengdu, Pan Penglin, Qin Yang, Wei Ruozheng, Zhao Yuhan, Fu Qixun, Yu Haixin, Liu Jiaying, Wu Heshui, Liu Zhiqiang, Zhou Yingke
Abstract excerpt
RNF43 is frequently inactivated by mutations in pancreatic ductal adenocarcinoma (PDAC), but the molecular mechanisms and therapeutic vulnerabilities associated with RNF43 loss remain poorly defined. Here, we demonstrate that RNF43 functions as an E3 ubiquitin ligase targeting YBX1 for degradation, thereby suppressing mitochondrial oxidative phosphorylation (OXPHOS). In RNF43-deficient PDAC models, stabilized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
